Abstract

The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.

Original languageEnglish
Pages (from-to)539-563
Number of pages25
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume52
Issue number2
DOIs
Publication statusPublished - Jan 2025

Keywords

  • Dual-energy X-ray absorptiometry (DXA)
  • Practice guideline
  • Procedures

Fingerprint

Dive into the research topics of 'Updated practice guideline for dual-energy X-ray absorptiometry (DXA)'. Together they form a unique fingerprint.

Cite this